Suggestions
Kristin Punzalan
Access Strategy Lead, Lung & Rare Cancers at Roche/Genentech
Professional Background
Kristin Punzalan is a dynamic collaborator with an impressive 19 years of experience in the healthcare sector. Her career has been marked by a commitment to providing strategic thinking and analytics in both Commercial and Operations organizations. She has expertise across several therapeutic areas, including oncology, Hepatitis C, Growth Hormone, and rare diseases. In her role as Access Strategy Lead for Lung and Rare Cancers at Genentech, Kristin has successfully navigated the complexities of the pharmaceutical landscape, ensuring that innovative treatments reach patients who need them most.
Kristin's career is characterized by her exceptional communication skills, which enable her to build strong relationships with colleagues and executives alike. Her results-oriented approach has made her an integral part of the teams she has worked with, where she is recognized not only for her analytical prowess but also for her leadership capabilities. As a people manager, Kristin excels at coaching and developing her direct reports, fostering an environment where team members can flourish and contribute effectively to the organization's goals. Her ability to implement innovative strategies has been instrumental in driving success in challenging commercial environments.
Education and Achievements
Kristin Punzalan’s educational foundation is robust and highly relevant to her professional journey. She studied for her Master of Business Administration (MBA) at the prestigious University of California, Berkeley, Haas School of Business. This education has equipped her with a deep understanding of business strategy, finance, and organizational behavior, which are essential skills in the fast-evolving healthcare industry. Prior to her MBA, Kristin obtained her Bachelor’s degree from the University of California, Santa Barbara, where she built a strong analytical background that serves as a cornerstone for her career achievements.
Throughout her professional career, Kristin has continually sought to enhance her knowledge and skills, staying abreast of the latest trends and advancements in healthcare and commercial strategies. Her commitment to lifelong learning is reflected in her ability to navigate new challenges and seize opportunities in various therapeutic areas.
Notable Achievements
Kristin Punzalan has made significant contributions to the healthcare field, particularly while working in roles that require an understanding of both the science behind therapies and the business acumen to bring them to market effectively. As part of her leadership at Genentech, she has been instrumental in developing strategies that enhance patient access to groundbreaking treatments for lung and rare cancers. Her innovative approaches in addressing the unique challenges within these therapeutic fields highlight her adaptability and forward-thinking mindset.
Her peers and executives recognize Kristin for her excellence in strategic planning and execution. She has effectively led cross-functional teams, ensuring that various stakeholders—from research and development to marketing—are aligned with the overarching objectives of the organization. As a result, Kristin has played a crucial role in launching successful campaigns and programs that not only meet business goals but also significantly impact patients’ lives.
In summary, Kristin Punzalan embodies the qualities of a dedicated healthcare professional: strategic thinker, effective communicator, and inspiring leader. Her extensive experience, combined with her strong educational background, positions her as a formidable force in the industry. As she continues to advance in her career, there is no doubt that Kristin will remain at the forefront of innovative healthcare solutions, dedicated to improving access and outcomes for patients across various therapeutic areas.
